Equity Overview
Price & Market Data
Price: $0.37
Daily Change: +$0.0022 / 0.60%
Daily Range: $0.342 - $0.375
Market Cap: $7,609,035
Daily Volume: 6,543
Performance Metrics
1 Week: 3.65%
1 Month: -20.69%
3 Months: -52.65%
6 Months: -61.08%
1 Year: -77.72%
YTD: -35.30%
Company Details
Employees: 8
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.